References
Key articles
Cherry JD. Parvovirus infections in children and adults. Adv Pediatr. 1999;46:245-69. Abstract
Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32(5):391-408. Abstract
Reference articles
1. Resuscitation Council UK. Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. May 2021 [internet publication].Full text
2. Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances. Resuscitation. 2021 Apr;161:152-219.Full text Abstract
3. Ijaz N, McMullen E, Singh M. Cutaneous drug rashes. Br J Hosp Med (Lond). 2015 Nov;76(11):C166-9. Abstract
4. Modi A, Desai M, Shah S, et al. Analysis of cutaneous adverse drug reactions reported at the Regional ADR Monitoring Center. Indian J Dermatol. 2019 May-Jun;64(3):250.Full text Abstract
5. Deng Q, Fang X, Zeng Q, et al. Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis. An Bras Dermatol. 2017 May-Jun;92(3):345-9.Full text Abstract
6. Valeyrie-Allanore L, Sassolas B, Roujeau JC. Drug-induced skin, nail and hair disorders. Drug Saf. 2007;30(11):1011-30. Abstract
7. National Institute for Health and Care Excellence. Drug allergy: diagnosis and management. September 2014 [internet publication].Full text
8. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001 Jun;137(6):765-70. Abstract
9. Böhm R, Proksch E, Schwarz T, et al. Drug hypersensitivity. Dtsch Arztebl Int. 2018 Jul 23;115(29-30):501-12.Full text Abstract
10. Bousquet PJ, Kvedariene V, Co-Minh HB, et al. Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy. 2007 Aug;62(8):872-6. Abstract
11. Plachouri KM, Vryzaki E, Georgiou S. Cutaneous adverse events of immune checkpoint inhibitors: a summarized overview. Curr Drug Saf. 2019;14(1):14-20. Abstract
12. Tan EH, Chan A. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors. Ann Pharmacother. 2009 Oct;43(10):1658-66. Abstract
13. Rosado Ingelmo A, Doña Diaz I, Cabañas Moreno R, et al. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Investig Allergol Clin Immunol. 2016;26(3):144-55.Full text Abstract
14. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011 May;71(5):684-700.Full text Abstract
15. Brandt O, Bircher AJ. Delayed-type hypersensitivity to oral and parenteral drugs. J Dtsch Dermatol Ges. 2017 Nov;15(11):1111-32.Full text Abstract
16. Blumenthal KG, Peter JG, Trubiano JA, et al. Antibiotic allergy. Lancet. 2019 Jan 12;393(10167):183-98.Full text Abstract
17. Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: an update. Am J Clin Dermatol. 2015 Dec;16(6):475-93. Abstract
18. Duong TA, Valeyrie-Allanore L, Wolkenstein P, et al. Severe cutaneous adverse reactions to drugs. Lancet. 2017 Oct 28;390(10106):1996-2011. Abstract
19. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction – results from the prospective RegiSCAR study. Br J Dermatol. 2013 Nov;169(5):1071-80.Full text Abstract
20. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011 Jul;124(7):588-97. Abstract
21. Drago F, Ciccarese G, Gasparini G, et al. Contemporary infectious exanthems: an update. Future Microbiol. 2017 Feb;12:171-93.Full text Abstract
22. Cherry JD. Viral exanthems. Curr Probl Pediatr. 1983 Apr;13(6):1-44. Abstract
23. Renn CN, Straff W, Dorfmuller A, et al. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol. 2002 Dec;147(6):1166-70. Abstract
24. Mancini AJ, Shani-Adir A. Other viral diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1255-320.
25. Celebi G, Pişkin N, Aydemir H, et al. Evaluation of 35 adult measles cases detected in a measles outbreak [in Turkish]. Mikrobiyol Bul. 2007 Jan;41(1):79-86. Abstract
26. Public Health England. National measles guidelines. November 2019 [internet publication].Full text
27. Cherry JD. Parvovirus infections in children and adults. Adv Pediatr. 1999;46:245-69. Abstract
28. Kimberlin DW. Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease. Pediatr Infect Dis J. 1998 Jan;17(1):59-67; quiz 68. Abstract
29. Porras B, Costner M, Friedman-Kien AE, et al. Update on cutaneous manifestations of HIV infection. Med Clin North Am. 1998 Sep;82(5):1033-80, v. Abstract
30. Dobson JS, Levell NJ. Spotting Zika spots: descriptive features of the rash used in 66 published cases. Clin Exp Dermatol. 2019 Jan;44(1):4-12.Full text Abstract
31. de Araújo TVB, Rodrigues LC, de Alencar Ximenes RA, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis. 2016 Sep 16;16(12):1356-63.Full text Abstract
32. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis. 2011;204(suppl 3):S810-16.Full text Abstract
33. Dallatomasinas S, Crestani R, Squire JS, et al. Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health. 2015 Apr;20(4):448-54. Abstract
34. WHO Ebola Response Team. Ebola virus disease in West Africa: the first 9 months of the epidemic and forward projections. N Engl J Med. 2014 Oct 16;371(16):1481-95.Full text Abstract
35. Lado M, Walker N, Baker P, et al. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2015 Sep;15(9):1024-33. Abstract
36. Gemmell CG. Staphylococcal scalded skin syndrome. J Med Microbiol. 1995 Nov;43(5):318-27. Abstract
37. Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J Am Acad Dermatol. 1994 Feb;30(2 Pt 2):319-24. Abstract
38. Hajjeh RA, Reingold A, Weil A, et al. Toxic shock syndrome in the United States: surveillance update, 1979-1996. Emerg Infect Dis. 1999 Nov-Dec;5(6):807-10.Full text Abstract
39. Reingold AL, Hargrett NT, Shands KN, et al. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med. 1982 Jun;96(6 Pt 2):875-80. Abstract
40. UK Health Security Agency. Scarlet fever: symptoms, diagnosis and treatment. Mar 2019 [internet publication].Full text
41. UK Health Security Agency. Group A streptococcal infections: report on seasonal activity in England, 2022 to 2023. Dec 2022 [internet publication].Full text
42. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15;55(10):e86-102.Full text Abstract
43. Committee on Infectious Diseases; American Academy of Pediatrics. Red book. 32nd ed. Elk Grove Village, IL: AAP; 2021.
44. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009 Mar 24;119(11):1541-51.Full text Abstract
45. Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, et al. Current perspectives on erythema multiforme. Clin Rev Allergy Immunol. 2018 Feb;54(1):177-84. Abstract
46. Buckingham SC, Marshall GS, Schutze GE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007 Feb;150(2):180-4. Abstract
47. Zeiser R, Blazar BR. Acute graft-versus-host disease: biologic process, prevention, and therapy. N Engl J Med. 2017 Nov 30;377(22):2167-79.Full text Abstract
48. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-99.Full text Abstract
49. National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. Nov 2021 [internet publication].Full text
50. Mehrpoor G, Owlia MB, Soleimani H, et al. Adult-onset Still's disease: a report of 28 cases and review of the literature. Mod Rheumatol. 2008;18(5):480-5. Abstract
51. Falcini F, Cimaz R. Juvenile rheumatoid arthritis. Curr Opin Rheumatol. 2000 Sep;12(5):415-9. Abstract
52. Vanden Hoek TL, Morrison LJ, Shuster M, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010 Nov 2;122(18 suppl 3):S829-61.Full text Abstract
53. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.Full text Abstract
54. National Institute for Health and Care Excellence. Sepsis: recognition, diagnosis and early management. September 2017 [internet publication].Full text
55. Royal College of Physicians. National early warning score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. December 2017 [internet publication].Full text
56. American College of Emergency Physicians (ACEP) Expert Panel on Sepsis. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. 2016 [internet publication].Full text
57. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text Abstract
58. Surviving Sepsis Campaign. Hour-1 bundle: initial resuscitation for sepsis and septic shock. 2019 [internet publication].Full text
59. Gottlieb M, Long B, Koyfman A. The evaluation and management of Rocky Mountain spotted fever in the emergency department: a review of the literature. J Emerg Med. 2018 Jul;55(1):42-50. Abstract
60. Nkoghe D, Leroy EM, Toung-Mve M, et al. Cutaneous manifestations of filovirus infections. Int J Dermatol. 2012 Sep;51(9):1037-43. Abstract
61. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. 2009 [internet publication].Full text Abstract
62. World Health Organization. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. 2011 [internet publication].Full text
63. World Health Organization. Handbook for clinical management of dengue. 2012 [internet publication].Full text
64. Ely JW, Seabury Stone M. The generalized rash: part II. Diagnostic approach. Am Fam Physician. 2010 Mar 15;81(6):735-9.Full text Abstract
65. Belum VR, Benhuri B, Postow MA, et al. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. Eur J Cancer. 2016 Jun;60:12-25.Full text Abstract
66. Berbis, P. Rickettsial diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1165-70.
68. Stary A. Sexually transmitted diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1271-81.
69. Blume JE, Levine EG, Heymann WR. Bacterial diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1117-44.
70. Evans AS, Niederman JC, Cenabre LC, et al. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1999 Nov-Dec;5(6):807-10. Abstract
71. Ferry T, Thomas D, Bouchut JC, et al. Early diagnosis of staphylococcal toxic shock syndrome by detection of the TSST-1 Vbeta signature in peripheral blood of a 12-year-old boy. Pediatr Infect Dis J. 2008 Mar;27(3):274-7. Abstract
72. Mirakian R, Ewan PW, Durham SR, et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009 Jan;39(1):43-61.Full text Abstract
73. Nigen S, Knowles SR, Shear NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol. 2003 Jun;2(3):278-99. Abstract
74. Hassoun-Kheir N, Bergman R1, Weltfriend S. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions. Int J Dermatol. 2016 Nov;55(11):1219-24. Abstract
75. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general consideration. Allergy. 2003 Sep;58(9):854-63. Abstract
76. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol. 2005 May;152(5):968-74. Abstract
77. Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32(5):391-408. Abstract
78. Cham PM, Warshaw EM. Patch testing for evaluating drug reactions due to systemic antibiotics. Dermatitis. 2007 Jun;18(2):63-77. Abstract
79. Lammintausta K, Kortekangas-Savolainen O. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol. 2005;85(6):491-6. Abstract
80. Centers for Disease Control and Prevention. Collecting and shipping specimens for suspected measles cases. November 2020 [internet publication].Full text
81. Windfuhr JP, Toepfner N, Steffen G, et al. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. Eur Arch Otorhinolaryngol. 2016 Apr;273(4):973-87.Full text Abstract
82. Cohen JF, Bertille N, Cohen R, et al. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016 Jul 4;7(7):CD010502.Full text Abstract
83. Lean WL, Arnup S, Danchin M, et al. Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis. Pediatrics. 2014 Oct;134(4):771-81. Abstract
84. Barakat AJ, Evans C, Gill M, et al. Rapid strep testing in children with recently treated streptococcal pharyngitis. Pediatr Investig. 2019 Mar;3(1):27-30.Full text Abstract
85. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis: United States. MMWR Recomm Rep. 2016 May 13;65(2):1-44.Full text Abstract
86. Centers for Disease Control and Prevention. Chikungunya virus: diagnostic testing. December 2018 [internet publication].Full text
Use of this content is subject to our disclaimer